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Available online 20 March 2008Extracellular matrix (ECM) binding to integrin receptors regulates cell cycle progression and survival. In
adherent cells, ECM disassembly induces anoikis, the apoptotic pathway switched on by loss of adhesion.
ECM-deﬁcient Ehlers–Danlos syndrome (EDS) ﬁbroblasts, to adhere to rare ﬁbronectin (FN) ﬁbrils, and to
proliferate, only organize, as FN receptor, the αvβ3 integrin. We report that in EDS cells the αvβ3 integrin is
bound to talin and vinculin, but not to tensin, and that actin cytoskeleton is disorganized. Furthermore, in EDS
cells Bcl-2 is down-regulated and caspases are active. We provide evidence that the antibody-mediated αvβ3
integrin or the FN inhibition induces anoikis in EDS cells. The αvβ3 integrin transduces survival signals to
pp60src-mediated tyrosine phosphorylated paxillin, instead than to FAK, and interacts with EGF receptor
(EGFR). This complex, when activated by EGF and FN, signals for the rescue of EDS cells from anoikis.
Therefore, EDS cells, through the αvβ3 integrin–EGFR complexes, engage a paxillin- but not FAK-mediated
pathway of cell survival.
© 2008 Elsevier B.V. All rights reserved.Keywords:
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Extracellular matrix (ECM) is a complex network of adhesive
proteins and proteoglycans, which regulates morphology, adhesion,
proliferation, migration and differentiation of mammalian cells. Dis-
ruption of cell–matrix interactions results in programmed cell death,
or anoikis [1–3], of ﬁbroblasts [4], endothelial [5], and epithelial cells
[6]. Anoikis drives physiological processes, i.e. morphogenesis, devel-
opment, tissue homeostasis, and wound repair, through the remodel-
ling of the ECM components.
ECM regulates anoikis through the action of integrins [3]. These
transmembrane αβ heterodimers [7] are clustered in matrix adhe-
sions distributed on the whole cell surface, when adherent cells grow
in 3D artiﬁcial matrices, or in focal and ﬁbrillar adhesions when they
are cultured in 2D [8,9].
Different integrins bind a single ECM component, and multiple
ligands can transduce differential signals through the same integrin
[10], and may be recognized by more than one integrin [11,12]. In each
cell type, depending on tissue origin and composition of the ECM,
anoikis activation or inhibition are likely mediated by peculiar in-
tegrins repertoires. The ﬁbronectin (FN)–α5β1 integrin complexes
rescue CHO cells from anoikis [13], and protect intestinal epithelial
cells against apoptosis caused by growth factors withdrawal [14]. The
β1-containing integrins, binding to laminin or collagens, signal for39 030 3701157.
l rights reserved.mammary epithelial cells survival [15], and αvβ3 integrins rescue
endothelial cells from apoptosis [16]. In tumor cells, the αvβ3 integrin
promotes growth and invasion,whereas its inhibition results in anoikis
and tumor regression [17].
Fibroblasts lacking ECM anchorage undergo growth arrest
[18,1,4,2]. FN regulates adhesion-dependent survival [19], and acts as
survival factor when ﬁbroblasts are grown in the absence of serum
[20]. Fibroblasts adhesion to FN is mediated by the α5β1 integrin, but
other FN receptors (FNRs), such as αvβ5 and αvβ1 integrins, can
support it. The αvβ3 integrin, a wide-range endothelial receptor,
which binds to vitronectin (VN), FN, von Willebrand factor, throm-
bospondin and ﬁbrinogen, is poorly organized in control ﬁbroblasts
[21,22].
The ECM-integrins binding regulates cell cycle progression through
the cyclin-dependent kinases [23], recruiting the tyrosine kinases, FAK
and Src family proteins [24], and activating the MAPK, the phosphoi-
nositide 3-kinase (PI3K) [25–27], the protein kinase B (PKB/AKT), and
JNK [28–30]. The over-expression of FAK down-regulates anoikis,
whereas ﬁbroblasts treatment with FAK antisense oligonucleotides
triggers apoptosis in spite of cell anchorage [24,31,32]. PKB/AKT acti-
vation inhibits the apoptotic death inducedbymatrix detachment [26].
PKB/AKT signaling inhibition induces the translocation of BAD to
mitocondria, themodiﬁcation of BAD/Bcl-2 ratio, caused by the down-
regulation of Bcl-2 [27], the activation of the apoptotic pathway by
cytochrome C release, and the subsequent activation of caspases
[33]. In turn, the proteolytic action of caspases targets intracellular
molecules such as PKB/AKT [34], FAK [35], p130Cas [36], paxillin,
tensin, and actin cytoskeleton [37–39]. In cultured ﬁbroblasts, FAK,
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are recruited by integrins in the focal adhesions, acting as structural
links between the ECM and actin cytoskeleton [10,8]. The ﬁbrillar
adhesions, extending on the whole cell membrane, contain α5β1 in-
tegrins associated with the extracellular matrix of FN and the
intracellular tensin, talin, and actin microﬁlaments [10,8,9]. Paxillin
phosphorylation by FAK or Src family proteins regulates, through its
binding to the adaptor molecules Crk and p130Cas, the cytoskeleton
organization and the cell shape,motility, and adhesion [40]. p130Cas is
also required for integrin-dependent EGFR activation, which in turn
leads to cell survival [41].
Ehlers–Danlos syndromes (EDS) are a heterogeneous group of
connective tissue disorders characterized by skin hyperestensibility,
articular hypermobility, and tissue fragility affecting skin, ligaments,
joints, blood vessels, and internal organs [42]. A typical clinical
hallmark of EDS is the impairedwound healing. Classical EDS, formerly
including type I and type II variants (EDSI and EDSII) [43] is an
autosomal dominant disorder due tomutations in COL5A1 andCOL5A2
genes encoding for type V collagen (COLLV) [44]. COLLV is a minor
component of tissues containing type I collagen such as skin, bone,
cornea, and blood vessels. Several isoforms exist, the most abundant
and widely distributed is the heterotrimer [α1(V)2α2(V)] that
coassembles with type I collagen, acting as a regulator of ﬁbrillar
diameter [45,46].Vascular EDS, formerly referred as type IV EDS
(EDSIV), is an autosomal dominant disorder due to mutations in
COL3A1 gene encoding for type III collagen (COLLIII) [47]. COLLIII, a
component of skin, tendon, aorta, and cornea is an α1(III)3 homotrimer
encoded by COL3A1 gene [46].
We reported that cultured dermal ﬁbroblast strains derived from
EDSI and EDSIV patients show a defective ECM assembly, as a con-
sequence of COL5A1 and COL3A1 genes mutations [22]. Both mutant
cell strains adhered in vitro and proliferated, though they showed
defective type V and III collagen (COLLV, COLLIII) synthesis, secretion
and organization into the ECM. The absence of COLLs in the matrix
down-regulated the organization of their receptor, the α2β1 integrin,
and its low levels led to αvβ3, instead of α5β1 integrin organization
and to the FN-ECM disassembly [22].
In this work we investigated, in the two previously characterized
EDS cell strains, the role of αvβ3 integrin in their adhesive and survival
properties. We report that these cells adhere to the substrate and
survive, though they lack the actin cytoskeleton and activate caspases.
The αvβ3 integrins support the adhesion and survival of these cells
through the binding to talin, vinculin, and pp60src kinase activated
paxillin, but not to FAK, and the cross-action with EGFR.
2. Materials and methods
2.1. Cell strains
Human control skin ﬁbroblasts were established in our lab from a skin biopsy of a
healthy donor. EDSI and EDSIV cells carrying missense dominantmutations in the genes
coding for α1 chains of COLLV (COL5A1: G1181C) and COLLIII (COL3A1: G769S), res-
pectively (22), were from Prof. A. De Paepe (Ghent, Belgium). The cells at the 4th in vitro
passages were grown at 37 °C in a 5% CO2 atmosphere in Earle's Minimal Essential
Medium (MEM) (Invitrogen) supplemented with 10% FBS (Invitrogen), 100 U/ml
penicillin and 100 μg/ml streptomycin (complete MEM).
2.2. Antibodies and reagents
Mouse anti-α5β1 (clone JBS5), -αvβ3 (clone LM609), -αvβ5 (clones 15F11 and P1F6),
and -αvβ6 (clone E7P6) integrins, anti-β1 (clone P4C10), and anti-β3 (clone PM6/13)
integrin subunits, anti-VN (clone BV2), and anti-vinculin (clone V284) monoclonal
antibodies (mAbs), and anti-phospho-serine (P-Ser) polyclonal antibody (Ab) were from
Chemicon. Anti-EGFR, -FAK, -talin, and anti-Bcl-2 Abs, anti-phospho-tyrosine (P-Tyr)
(PY20), anti-αv integrin subunit (clone p2W7), anti-p130Cas (clone 35B.1A4), and anti-
GAPDH (clone 0411) mAbs were from Santa Cruz Biotechnology. Anti-ILK mAb (clone
65.1.9) was from Upstate, and rabbit anti-pp60src Abwas from Cell Signalling Technology.
The function blocking anti-EGFR (clone 225)mAb, FITC- and TRITC-conjugated goat anti-
rabbit and anti-mouseAbswere fromCalbiochem-Novabiochem. Thehorseradishperoxidase
(HRP)-conjugated secondary Abs, bovine serum albumine (BSA), FITC-phalloidin, anti-FNAb,puriﬁed humanplasma FN (pFN), and vitronectin (VN), human recombinant EGF and human
IgGswere fromSigma Chemicals. The f33 anti-human FNmAb recognized an epitope located
in the C terminus of the 120–140-kDa catheptic FN fragment, located downstream of the
collagen-domain, [48]. The function blocking anti-FN (clone HFN7.1) mAb was from Neo-
Markers. Anti-tensin (clone 5), and anti-paxillin (clone 165) mAbs were from BD Biosciences
Pharmingen. PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo [3,4-d] pyrimidine), and
its inactive analogue PP3 were a gift from Prof. M. Rusnati (Brescia, Italy).
For the TUNEL assay the Apoptag Fluorescein direct in situ kit was from Serological-
Resnova. The carboxyﬂuorescein FLICA assay kit was from B-Bridge.
2.3. Indirect immunoﬂuorescence (IF) microscopy
The α5β1, αvβ5, αvβ3, αvβ6, αv, and β1 integrins distribution and talin, vinculin, tensin,
FAK, and paxillin organization were analyzed by IF on 1.5×105 cells grown for 48 h on glass
coverslips in completeMEM. The cells,ﬁxed in 3% PFA and60mMsucrose andpermeabilized
in 0.5% Triton X-100, were reacted with 1 μg/ml anti-α5β1, anti-β1, anti-αv integrins mAbs,
2 μg/ml anti-vinculin, anti-paxillin, and anti-tensin mAbs, 4 μg/ml anti-αvβ3 and anti-αvβ6
integrinmAbs and 1:100 dilution of anti-FAK, and anti-talin Abs. Alternatively, in order to co-
localize theseproteins, EDS cells cultured for 1, 8, 24and48h,were immunoreactedwithboth
anti-talin Ab and anti-αvβ3 integrin mAb. The effect of α5β1 integrin function inhibition on
the organization of this receptor and of αvβ5 and αvβ3 integrinswas studied treating control
cells for 48 h with 10 μg/ml anti-α5β1 function blocking mAb. The effect of EGFR function
inhibitiononαvβ3 integrinorganizationwasanalyzed treating the cells for 24hwith10 μg/ml
function blocking anti-EGFRmAb and immunoreacting with 2 μg/ml anti-EGFR Ab, and anti-
αvβ3 integrin mAb. To analyze the cytoskeleton, the cells were reacted with 100 ng FITC-
phalloidin or with 1 μg/ml anti-tensin mAb.
The Bcl-2 protein expressionwas analyzed reacting cells with 1:50 anti-Bcl-2 Ab. To
analyze the αvβ5 integrin organization, the cells ﬁxed in acetone were reacted with
1 μg/ml anti-αvβ5 integrinmAb. The caspases activitywas studied using the FLICA assay
kit, according to the supplier's instructions.
To analyze the FN organization, the 48 h and 8 d grown cells cultures ﬁxed in
methanol were incubated with the speciﬁc anti-FN Ab or with the anti-FN mAb f33.
Alternatively, the FN-ECM organizationwas analyzed 24 h after seeding, in the presence
and in the absence of FBS, either with the anti-FNAb or the f33mAb. Cells grown in FBS-
free medium were seeded in complete MEM and, after spreading, washed three times
and refed with serum-free medium.
In all IF experiments the cells were then reacted with FITC- or TRITC-conjugated
anti-rabbit or anti-mouse IgG. The IF signals were acquired by a CCD black/white TV
camera (SensiCam-PCO Computer Optics GmbH, Germany) mounted on a Zeiss
ﬂuorescence-Axiovert microscope, and digitalized by Image Pro Plus program (Media
Cybernetics, Silver Spring, MD).
2.4. Cell adhesion assay
1×104 cells were detached with 500 μg/ml trypsin and 200 μg/ml EDTA. Trypsin
activity was inhibited by washing the cells with 1 mg/ml soybean trypsin inhibitor
(Sigma Chemical Co.) The cells, treated or not with 10 μg/ml anti-αvβ3, -α5β1, -αvβ5
integrin, and anti-β1 integrin subunit function blocking mAbs, were seeded, in the
presence of complete MEM and the blocking Abs, on uncoated and 10 μg/ml pFN-coated
wells for 30 and 60 min at 37 °C. In order to ascertain the function blocking role of the
inhibiting anti-FN and anti-VNmAbs (clones HFN7.1 and BV2, respectively), control and
EDS cells, treated or not with 30 μg/ml anti-FN or anti-VN blocking mAbs, were seeded
on pFN or VN-coated wells, respectively. The wells were coated overnight at 4 °C with
10 μg/ml puriﬁed pFN or VN, and blocked for 60 min at 37 °C with 1% BSA in PBS. Cells
were ﬁxed in methanol and stained in Giemsa solution. All cells adhering to the
substratewere counted 30 and 60min after seeding by a lightmicroscope. The adhesion
assay was repeated for each condition in triplicate for three times.
2.5. Apoptosis assay
1×105 cells, detached from culture dishes with 0.05% trypsin/0.02% EDTA, were
washed and seeded on coverslips in complete MEM. The αvβ3 integrin and EGFR
functions were inhibited, 1 h after seeding, adding for 48 h 10 μg/ml anti-αvβ3 integrin
or anti-EGFR function blocking mAbs, or an anti-αvβ3 and anti-EGFR Abs mixture. In
parallel, the cells were treated with 10 μg/ml anti-α5β1 or anti-αvβ5 integrin function
blocking mAbs, or with irrelevant human IgGs. Alternatively, the ﬁbroblasts 16 h after
seeding were washed with serum-free MEM and maintained in the absence of serum
for 48 h in medium supplemented or not with 12.5 nM human recombinant EGF.
The FN and VN assembly was inhibited adding,1 h after cells seeding, 30 μg/ml anti-
FN and anti-VN blocking mAbs, respectively.
The pp60src kinase activity was inhibited growing the cells for 48 h in complete
MEM and treating for 20 h with 100 μM PP2 or PP3.
For the analysis of anoikis, DNA fragmentation was detected by staining the cells
with Apoptag TUNEL system, according to supplier's instructions. After the TdT
reaction, the nuclei were counterstained with propidium iodide. The percent value of
apoptotic cells was evaluated by the epiﬂuorescence Zeiss microscope, counting the
number of the fragmented nuclei versus the total cells scored on the slide (about
0.9×105). The cells maintained for 24 h in the presence of anti-EGFR function blocking
mAb or in serum-free MEM, in the presence of puriﬁed EGF, were also analyzed for the
αvβ3 integrin organization by IF, as reported above.
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The integrins organized by cells grown for 48 h in complete MEM were extracted
with 1% Triton X-100, 50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2,
proteases and phosphatases inhibitors (10 μg/ml leupeptin, 4 μg/ml pepstatin and
0.1 KIU/ml aprotinin, 10 mM NaF, 10 mM Na4P2O7, 1 mM Na3VO4). The protein
concentrationwas evaluated by the detergent compatible Bio-RadDC Protein Assay (Bio-
Rad Laboratories). Proteins were immunoprecipitated with anti-αv integrin subunit
mAb (10 μg of Ab/1 mg of protein), in the presence of protein G (Pierce) diluted in TBS.
The bound proteins, puriﬁed by boiling in 1% SDS,were separated by7% SDS-PAGE under
reducing conditions and immunoblotted with the anti-αvmAb (1 μg/ml) diluted in TBS-
0.1% Tween 20 (TBS-T). After the detection, the ﬁlter was stripped and incubated with
1 μg/ml anti-β3 and anti-β1 integrin subunits mAbs. The αvβ3 precipitates obtained
using 10 μg anti-αvβ3 integrinmAb/1mgof proteinwere reactedwith 1 μg/ml anti-αvβ3
integrin mAb and, subsequently, with 0.2 μg/ml anti-P-Tyr mAb diluted in TBS-T. The β3
integrin subunits precipitated with 10 μg/1 mg protein anti-β3 integrin mAb were
immunoblottedwith the anti-β3 integrin subunit, anti-P-Tyr, and anti-paxillin (2 μg/ml)
mAbs, and with anti-FAK Ab (1:100).
Paxillin and its tyrosine phosphorylation were analyzed in cells grown for 48 h and
treated or not for 1 hwith 100 μMPP2 and PP3. Cell extracts, recovered in the lysis buffer
containing 10 mM Tris–HCl pH 7.4 were immunoprecipitated with 10 μg anti-paxillin
mAb and immunoblotted with anti-paxillin, anti-P-Tyr, 4 μg/ml anti-P-Ser and 2 μg/ml
anti-ILK mAbs. Alternatively, paxillin immunoprecipitates were reacted with 1:500
rabbit anti-pp60src Ab and 2.5 μg/ml anti-p130Cas mAb.
To analyze EGFR, the cells, grown for 48 h, were extracted with 1% NP-40, 150 mM
NaCl, 50 mM Tris–HCl pH 8.0 lysis buffer containing 5 mM EDTA, and phosphatases and
proteases inhibitors. Proteins were precipitated with the anti-EGFR Ab and the
immunocomplexes were recovered in 1% SDS/β-mercaptoethanol, separated in 8% SDS-
PAGE, and reacted with 1:100 anti-EGFR Ab, 1:500 anti-GAPDH, anti-αvβ3 integrin, and
anti-P-Tyr mAbs. Alternatively, crude cell extracts were immunoreacted with the not-
related anti-GAPDH mAb, as control.
The detections were performed using horseradish peroxidase-conjugated anti-
rabbit or anti-mouse secondary Abs and the ECLmethod (Pierce). The semi-quantitativeFig. 1. EDS cells, assembling rare FN ﬁbrils in the ECM (A), organize the αvβ3 integrin and red
was detected with the anti-FN Ab. In EDS cells FN ﬁbrils were preferentially localized in the
EDSI and EDSIV cells was detected by IF analysis with the anti-α5β1, anti-αvβ5, anti-αvβ3 m
subunits mAbs, in two separated experiments. In EDS cells, the αv subunit distribution resem
focal adhesions and as a diffused cytoplasmic signal. Scale bar, 10 μm. B: Western blotting of
and anti-β3 integrin subunits mAbs. In EDS cells the αv subunits preferentially co-immunoevaluation of the integrated optical density (IOD) of the bands was performed by
Analytical Imaging Station (AIS) software (Imaging Research INC., Ontario, Canada). The
ratio between the IOD values in EDS cells and control cells were calculated.
3. Results
3.1. The αvβ3 integrin is the main adhesive receptor of FN-ECM deﬁcient
EDS ﬁbroblasts
To study the FN organization in the ECM of EDS cells, IF analysis
was performed using a speciﬁc Ab. As previously reported [22], EDSI
and EDSIV ﬁbroblasts grown to conﬂuence, contrary to control
ﬁbroblasts, did not assemble the FN-ECM, and showed only rare FN
ﬁbrils in the extracellular spaces and localized at cell adhesion sites
(Fig. 1A). The same organization of FNwas detected in control and EDS
cells with an anti-human-speciﬁc-FN mAb (Supplementary Material 1
to Fig. 1A), thus indicating that the FN detected was of cellular origin.
This FN distribution was observed in EDS cells not only after 48 h, but
also after 8 d from seeding (Supplementary Material 2 to Fig. 1A). The
FN organization was observed in control cells maintained for 24 h in
the absence of FBS (Supplementary Material 3 to Fig. 1A). In this
condition, EDS cells were synthesizing FN, and few ﬁbrils were
detected in the extracellular space, although, the cells were not fully
spread. The characterization of soluble FN levels secreted in the
culture media by EDSI and EDSIV cell strains has been previously
reported to be 5- and 14-fold respectively reduced, compared to
control cells [22]. This suggests that the reduced ﬁbrillogenesis in EDSuced amounts of α5β1, αvβ5 (A) and αvβ1 (A,B) integrins. A: The FN-ECM organization
intercellular spaces at the peripheral cell contacts. The integrins distribution in control,
Abs and, as any anti-αvβ1 integrin Ab was available, with anti-αv and anti-β1 integrin
bled that of αvβ3 integrin, whereas the β1 subunit was organized in linear patches in the
αv immunoprecipitates from control, EDSI and EDSIV cells reacted with anti-αv, anti-β1
precipitated with β3, rather than β1 integrin subunits.
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and that EDS cells adhere to the substrate through reduced amounts of
FN ﬁbrils.
To identify which FNRs were organized by EDSI and EDSIV versus
control ﬁbroblasts strains, IF analysis was performed with speciﬁc
mAbs directed against α5β1, αvβ5, αvβ3, and αvβ6 FNRs, and against
the αv and β1 integrin subunits forming the αvβ1 FNR. The α5β1
integrin, organized over the whole cell surface of control ﬁbroblasts,
was present only in peripheral adhesion contacts and at the boundary
between the cells in both EDS cell strains (Fig. 1A). Furthermore, these
cells showed a strong reduction of αvβ5 integrin, as compared to
control cells. The αv integrin subunits were organized on the entire
surface of control and EDS cells (Fig. 1A). On the contrary, β1-con-
taining integrins were detected as linear patches in focal contacts of
EDS cells, whereas in control cells, they were present on the whole
cell surface. In EDS cells, the β1 subunit was also detectable in the
cytoplasm. The analysis of αvβ1 integrin dimers was performed by
Western blotting of the αv integrin subunits immunoprecipitated
from control and EDS cells, and reacted with the anti-β1 integrin mAb.
EDSI and EDSIV cells showed decreased levels (2.3 and 2.7-fold, res-
pectively) of β1 subunits bound to the αv monomers, as comparedFig. 2. The αvβ3 integrins support EDS cells adhesion to the substrate and to FN (A,B) an
EDSIV cells were seeded in the presence of FBS on uncoated (A) and 10 μg/ml pFN-coated (B
anti-αvβ5 and anti-β1 integrin function blockingmAbs andwere counted 30 and 60min afte
seeded cells (1×104) in three independent experiments performed in triplicate. The standard
EDSI and EDSIV cells extracts, recovered 48 h after seeding, were immunoreacted with theto control cells, thus indicating that these cells organized reduced
amounts of αvβ1 integrin (Fig. 1B).
In EDS cells, the decrease of α5β1, αvβ5, and αvβ1 FNRs was
associatedwith the organization ofαvβ3 integrin inpatches detectable
on thewhole cell surface, not only 48 h after cells seeding (Fig.1A), but
also after several days in conﬂuent cultures (not shown). The αvβ3
integrin patches were rarely observed by IF in the peripheral adhesion
contacts of control ﬁbroblasts (Fig. 1A). Accordingly, the β3 integrin
subunitwas almost undetectable in these cells, butwas present at high
levels in EDS cells, and co-immunoprecipitated with the αv subunit
(Fig. 1B). The αv subunit was detected in EDSI and EDSIV cells at
higher levels (2.0 and 2.1-fold, respectively), as compared to control
ﬁbroblasts (Fig. 1B). The αvβ6 integrinwas not detected by IF either in
EDS or in control ﬁbroblasts (Fig. 1A). These data, conﬁrmed by FACS
analysis [22 and not shown], show that the αvβ3 integrin is the main
adhesive FNR present on the cell surface of EDS ﬁbroblasts.
3.2. The αvβ3 integrin supports EDS cells adhesion
To verify whether in EDS cells the αvβ3 integrin was bound to FN,
an adhesion assay was performed in the absence and in the presenced are maintained activated through tyrosine phosphorylation (C). Control, EDSI and
) substrates in the absence (Untreated) and in the presence of the anti-αvβ3, anti-α5β1,
r seeding. The numbers reported are average percent values calculated on the number of
deviation (SD) was ≤2%. C: αvβ3 integrins obtained by immunoprecipitation of control,
anti-αvβ3 integrin and anti-P-Tyr mAbs.
Fig. 3. The αvβ3 integrins rescue EDS ﬁbroblasts from anoikis cross-acting with EGFR. A: Control, and EDS cells grown in complete medium in the absence (Untreated) and in the
presence of 10 μg/ml anti-αvβ3 integrin function blockingmAb (+ anti-αvβ3),were analyzed by TUNEL assayand nuclei were counterstainedwith 10 μg/ml propidium iodide. Scale bar,
50 μm. B: Control, EDSI and EDSIV cells grown in complete medium in the absence (Untreated) and in the presence of 10 μg/ml anti-αvβ3 integrin (+ anti-αvβ3), or anti-EGFR (+ anti-
EGFR) function blockingmAbs, or in the presence of amixture of anti-αvβ3 and anti-EGFR function blockingmAbs (+ anti-αvβ3, +anti-EGFR), or in the presence of 30 μg/ml anti-FN and
anti-VN mAbs, were analyzed by TUNEL assay. The percent values of fragmented nuclei are means±SD of three independent experiments performed in triplicate. C: The inhibition of
FN induced the FN-ECMdisorganization in control cells, and the disappearance of FNﬁbrils andαvβ3 integrins in EDS cells, which showed an apoptotic phenotype. The treatment of all
cell types with human puriﬁed pFN (10 μg/ml) induced the organization of a richer FN-ECM in control cells and of a ﬁbrillar FN-ECM overlaying the cells, in EDS ﬁbroblasts. EDS
cells organized αvβ3 integrins in the ﬁbrillar adhesions; the linear patches of αvβ3 integrins were shorter then in untreated cells, likely as a consequence of their interaction with
the FN-ECM. Scale bar, 10 μm. D: Western blotting of EGFR immunoprecipitates from equal amounts of proteins from control, EDSI, and EDSIV cell lysates were immunoreacted with
anti-EGFR Ab, anti-αvβ3 integrin, anti-P-Tyr, and anti-GAPDHmAbs. As loading control, equal amounts of crude cell lysates from control and EDS cells were immunoreacted with the
anti-GAPDH mAb.
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Fig. 3 (continued).
1182 N. Zoppi et al. / Biochimica et Biophysica Acta 1783 (2008) 1177–1188of a pFN coating, before and after αvβ3 integrin inhibitionwith a speciﬁc
function blocking mAb [49]. The adhered cells were counted 30 and
60 min after seeding. In the absence of coating and αvβ3 inhibition, 78%
and 100% EDSI and EDSIV cells, respectively, adhered to the substrate after
60 min (Fig. 2A). At this time, 87% control cells adhered to the substrate
(Fig. 2A). After αvβ3 inhibition, at 60 min of adhesion, all control cells
adhered to the substrate, whereas only about 11–14% EDS ﬁbroblasts
adhered. The functional inhibition of α5β1, αvβ5, or β1-containing inte-
grins with speciﬁc blocking mAbs did not affect either EDS or control
ﬁbroblasts adhesion (Fig. 2A). The α5β1 integrin functional inhibition in
controlﬁbroblasts downloaded theorganization of this integrin andof the
αvβ5 receptor, which was mainly detectable in focal adhesions (Supple-
mentary Material 1 to Fig. 2A,B). The decrease of these integrins was
paralleled by the organization ofαvβ3 integrin in the focal adhesions. This
indicates that the in vitro adhesion of EDS, but not of control cells, is
mediated by αvβ3 integrin. The disorganization of FN and α5β1 and αvβ5
integrin, and the organization of αvβ3 integrin were observed in dermal
ﬁbroblasts from different EDS types [50–52].
Untreated control and EDS cells adhered to pFN with similar
efﬁciency. After αvβ3 inhibition, control ﬁbroblasts adhesion to FN
was delayed, but about 83% of the cells adhered 60 min after seeding.
In the same conditions, only about 9% and 16% EDSI and EDSIV cells,
respectively, adhered to pFN (Fig. 2B). These data show that αvβ3
integrin plays a role in the early adhesion events in control ﬁbroblasts
and supports EDS ﬁbroblasts adhesion to pFN.
The inhibition of α5β1 and αvβ5 dimers, and of β1 integrin
subunit by function blocking mAbs, at 60 min after seeding, did not
affect the adhesion of control and EDS cells on pFN-coated substrate
(Fig. 2B).
The αvβ3 integrins, organized by EDS cells after 48 h in cul-
ture (Fig. 1A), were analyzed for their phosphorylation by Western
blotting of αvβ3 integrins immunoprecipitates. The immunoreaction
with an anti-P-Tyr mAb showed that in EDSI and EDSIV ﬁbroblasts the
αvβ3 integrin, detected as a 250 kD band, was tyrosine-phosphory-
lated (Fig. 2C). The semi-quantitative analysis of the bands showed
that the levels of αvβ3 integrin and its phosphorylation in EDSI cells
were 2.2 and 1.9-fold higher, and in EDSIV cells were 2.9 and 2.5-fold
higher than in control ﬁbroblasts. Therefore, the αvβ3 integrins are
present in EDS cells in an active form, likely transducing signals inside
the cells.3.3. The αvβ3 integrin rescues EDS ﬁbroblasts from anoikis
Since in cultured ﬁbroblasts the defective FN-ECM organization
might act as an apoptotic signal, we further veriﬁed in EDS cells,
lacking a ﬁbrillar FN matrix, the αvβ3 integrin involvement in the
transduction pathways preventing anoikis. For this purpose, the αvβ3
integrin was inhibited in control and EDS ﬁbroblasts adhered to the
substrate, by anti-human αvβ3 integrin function blocking mAb. The
ability of EDS cells to undergo apoptosis was tested analyzing the DNA
fragmentation by the TUNEL assay (Fig. 3A). In the absence of anti-
αvβ3 integrinmAb, the percentages of fragmented nuclei were similar
in all strains and lower than 2% (Fig. 3B), whereas afterαvβ3 inhibition,
but not after treatmentwith an irrelevant human IgG (not shown), EDS
cells massively activated the apoptotic pathway (Fig. 3A,B). In
particular, 41% and 55% fragmented nuclei were counted in EDSI and
EDSIV cells, respectively, whereas 4% fragmented nuclei were counted
in control cells (Fig. 3A,B). These data show that in EDS ﬁbroblasts the
αvβ3 integrin functional inhibition leads to the apoptotic pathway
activation. The EDS cells did not undergo apoptosis after α5β1 or αvβ5
integrins inhibition (Supplementary Material 1 to Fig. 3B), thus
indicating that these integrins are not involved in their survival.
In order to investigate whether in EDS cells the rare FN ﬁbrils
binding toαvβ3 integrin could activate the integrin-mediated survival,
FN ﬁbrils deposition was inhibited with a speciﬁc function blocking
mAb (Supplementary Material 2 to Fig. 3B), and the levels of apoptosis
induced in control and EDS cellswere analyzed (Fig. 3B). The treatment
of EDS cells with anti-FN mAb induced the disorganization of αvβ3
integrin (Fig. 3C) and the apoptosis in about 60% of the cells, whereas
only 4% control ﬁbroblasts underwent apoptosis in these conditions
(Fig. 3B,C). The inhibition with a speciﬁc function blocking mAb of
another known αvβ3 integrin ligand, i.e., VN, preventing the adhesion
of control and EDS cells on VN-coated substrate (Supplementary
Material 2 to Fig. 3B), did not change the percentage of apoptotic nuclei
detected in all cell types, compared with the untreated counterparts
(Fig. 3B), and did not modify their FNR integrins proﬁles (not shown).
These results indicate that EDS ﬁbroblasts do not undergo apoptosis
when FN is present, and that the down-regulation of FN leads to αvβ3
integrin disorganization and to anoikis.
The treatment of control and EDS cells with 10 μg/ml pFN induced
in all cell types the organization of a ﬁbrillar FN-ECM (Fig. 3C). In this
condition the αvβ3 integrin, but not the other FNRs (not shown), was
organized in EDS cells and was capable to support the assembly of a
ﬁbrillar FN-ECM.
3.4. The αvβ3 integrin rescues EDS ﬁbroblasts from anoikis by a cross-
action with EGFR
To investigate whether in EDS cells the αvβ3 integrin binding to a
poorly organized FN-ECM was cross-acting with other surface
receptors known to transduce for the rescue from apoptosis, we ana-
lyzed the role of EGFR in EDS cells survival. For this purpose, control,
and EDS ﬁbroblasts, seeded in complete medium, were treated with
10 μg/ml function blocking anti-EGFR mAb. In these conditions, 1.8%
controlﬁbroblasts, 38% EDSI and 50% EDSIV cells underwent apoptosis,
as detected by TUNEL staining (Fig. 3B). These data show that also the
EGFR function inhibition induces apoptosis in EDS.
The possible cooperation between EGFR and αvβ3 integrin was
investigated bymAbs-mediated αvβ3 integrin and EGFR simultaneous
function blocking. Under these conditions, 70% of EDS cells nuclei
were fragmented, whereas only 4.8% were detected in control ﬁb-
roblasts (Fig. 3B). These results show that the number of EDS cells
undergoing anoikis increased when both αvβ3 integrin and EGFR
were inhibited, compared with the apoptotic cells number detected
when these two receptors were inhibited separately (Fig. 3B). There-
fore, both EGFR and αvβ3 integrin seem to be involved in EDS cells
survival and might cooperate to maintain EDS cells survival.
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drawal was a feature common to other EDS ﬁbroblast strains deﬁ-
cient for the FN-ECM assembly and organizing the αvβ3 integrin (not
shown).
In EDS cells, the EGFR activity elicited the assembly and
localization of αvβ3 integrin on the whole cell surface. Indeed,
αvβ3 integrin disappeared from the ﬁbrillar adhesion sites when
EGFR was inhibited (Supplementary Material 3 to Fig. 3B), and the
functional inhibition of both receptor gave rise to EDS cells apoptotic
phenotype (Fig. 3B). Puriﬁed EGF, exogenously added to serum-free
medium grown EDS ﬁbroblasts, almost completely rescued these
cells from apoptosis induced by serum starvation, without affecting
the αvβ3 integrin organization (Supplementary Material 4 to Fig.
3B). These data show that in EDS cells, a co-operation between αvβ3
and EGFR may occur, and should be involved in promoting a survival
mechanism.
In order to investigate whether αvβ3 integrin and EGFR interacted
in EDS cells, EGFR was immunoprecipitated from cells membranes
extracts, recovered 48 h after cells seeding, and its binding to αvβ3
integrin was analyzed by Western blotting. The immunoprecipitatesFig. 4. EDS cells organize in ﬁbrillar and focal adhesions vinculin and talin, co-localize talin w
was performed on 48 h grown control, EDSI and EDSIV ﬁbroblasts using anti-talin Ab, anti-v
αvβ3 integrin and talin double immunostaining was performed reacting control and EDS ﬁbr
(yellow). Scale bar, 6 μm.from control and EDS cells were reacted with anti-EGFR and anti-
αvβ3 integrin Abs. EGFR, detected as a 180 kDa band, was present in
control and, at higher levels (2.1 and 2.7-fold, respectively) in EDSI
and EDSIV ﬁbroblasts membranes, and co-immunoprecipitated with
the αvβ3 integrin (Fig. 3D). The semi-quantitative analysis of the
bands showed that in EDSI and EDSIV cells the αvβ3 integrin
amounts bound to EGFR were 2.6 and 2.0-fold, respectively, higher
than in control ﬁbroblasts.
The analysis of αvβ3 integrin-EGFR complexes phosphorylation,
detected with an anti-P-Tyr mAb, showed that both receptors were
phosphorylated either in control or in EDS cells (Fig. 3D). In particular,
the phosphorylated αvβ3 integrins, detected as 250 bands, were 1.8-
and 2.6-fold higher in EDSI and EDSIV cells than in control ﬁbroblasts.
EGFR, detected as 180 kDa bands, was 2.0- and 3.1-fold higher in EDSI
and EDSIV cells than in control ﬁbroblasts (Fig. 3D). These data show
that in EDS cells EGFR is maintained in a phosphorylated state and at
higher levels than in control cells, bound to the active αvβ3 integrin.
These data suggest that theαvβ3 integrin and EGFRmight cooperate in
the maintenance of survival signals transduction preventing EDS cells
anoikis.ith αvβ3 integrin, but do not assemble the tensin and actin cytoskeleton. A: IF analysis
inculin and anti-tensin mAbs, and FITC-conjugated phalloidin. Scale bar, 10 μm. B: The
oblasts with an anti-αvβ3 mAb (red) and anti-talin Ab (green), and merging the signals
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cells
Control and EDS ﬁbroblasts were analyzed for the distribution of
the cell adhesions proteins talin, vinculin and tensin, and for the
organization of actin cytoskeleton. The IF performed with speciﬁc
Abs, 48 h after cells seeding, showed that control ﬁbroblasts
organized talin on the whole cell membrane and vinculin in focal
contacts, whereas EDS cells organized both proteins on thewhole cell
surface (Fig. 4A), with a distribution resembling that of αvβ3 integrin
patches (Fig. 1A). This was also conﬁrmed by the co-localization of
talin with the αvβ3 integrin patches, after the merge analysis of the
two IF signals obtained on the same cells (Fig. 4B). The co-localization
of talin with the αvβ3 integrin patches was detected in EDS cells
starting from 1 h after seeding (Supplementary Material 1 to Fig. 4B).
Tensin, organized on the whole cell surface in control cells, was
strongly reduced and preferentially localized in focal contacts in
EDS cells (Fig. 4A). Actin cytoskeleton, analyzed by FITC-phalloidinFig. 5. The αvβ3 integrin transducing signals to paxillin but not to FAK does not rescue from c
were analyzed by IF with the anti-FAK and anti-Bcl-2 Abs and with anti-paxillin mAb. Caspa
active caspases. The peptide binding was detected by a secondary FITC-conjugated Ab. Scale
EDSI and EDSIV cells extracts, recovered 48 h after cell seeding, were reacted with anti-β3reaction, was strongly reduced in EDS cells, compared to control
ﬁbroblasts (Fig. 4A).
These data suggest that in EDS cells theαvβ3 integrin recruits in cell
contacts talin and vinculin, but not tensin, and that these proteins do
not efﬁciently support the actin cytoskeleton organization. Since
in cultured ﬁbroblasts the defective cytoskeleton organization might
be a downstream effect of apoptotic signals, the expression of the anti-
apoptotic protein Bcl-2 in control and EDS ﬁbroblasts was analyzed
by IF with an anti-Bcl-2 Ab. Fig. 5A shows that whereas in control
ﬁbroblasts Bcl-2 protein was detectable as cytoplasmic and nuclear
signals, it was undetectable in EDS cells. Furthermore, the caspase
activity, absent in control cells,waspresent in the cytoplasmandnuclei
of EDS cells, after carboxyﬂuorescein FLICA assay. These data indicate
that these proteases are active in EDS, but not in control ﬁbroblasts and
might have a role in the actin cytoskeleton disassembly.
These data show that ECM and cytoskeleton deﬁcient EDS cells,
though showing adhesive features comparable with those of control
ﬁbroblasts, down-regulate Bcl-2 and activate apoptotic enzymes.aspases activation. A: Control, EDSI and EDSIV cells grown for 48 h in complete medium
se activity was analyzed using a broad range peptide FLICA binding to and inhibiting all
bar, 10 μm. B: Western blotting of β3 integrin subunit immunoprecipitates from control,
integrin subunit, anti-P-Tyr, anti-FAK and anti-paxillin Abs.
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by a FAK-independent and paxillin-mediated transduction pathway
To investigate the transduction pathway activated by αvβ3
integrin–EGFR complexes, signalling for cell survival in the absence
of Bcl-2 and in the presence of caspases activity, the distribution
of FAK and paxillin was analyzed in control and EDS ﬁbroblasts.
The IF analysis, performed 48 h after cells seeding showed that
FAK patches were detectable only in control cells (Fig. 5A). In con-
trol cells, paxillin was mainly localized in focal adhesion contacts,
whereas in EDS cells it was detectable on the whole plasma
membrane (Fig. 5A).
The interaction between αvβ3 integrin, FAK and paxillin was
further investigated by immunoprecipitating the β3 integrin subunits
from control and EDS cell membranes extracts, and analyzing them by
Western blotting with anti-β3 integrin subunit, anti-FAK, and anti-
paxillin Abs. The β3 subunit was 2.0-fold higher in EDS cells than in
control ﬁbroblasts, and the β3 phosphorylated subunit was 2.6- and
4.7-fold higher in EDS cells than in control ﬁbroblasts. The FAK binding
to the tyrosine-phosphorylated β3 integrin subunit was detected only
in control ﬁbroblasts (Fig. 5B), thus suggesting that the αvβ3 integrin–
EGFR complexes organized by EDS cells should transduce survival
signals by a FAK-independent pathway.
Paxillin, organized on the whole surface of EDS cells (Fig. 5A), co-
immunoprecipitated with β3 integrin subunit (Fig. 5B). Therefore, in
EDS cells the αvβ3 integrin–EGFR complexes, not recruiting FAK,
should bind to paxillin.Fig. 6. The αvβ3 integrin signals to pp60src-mediated tyrosine, but not serine, phosphoryla
grown control, EDSI and EDSIV cells, were immunoblotted with anti-paxillin, anti-P-Tyr, an
phosphorylated paxillin co-immunoprecipitates with higher pp60src levels and lower p
immunoprecipitates, from control, EDSI and EDSIV cells grown for 48 h and treated for 1 h wi
anti-P-Tyr mAbs. In control and EDS cells treated with PP2 or PP3, paxillin was detectable at
analogue PP3 (A). PP2 treatment reduced the tyrosine phosphorylation of paxillin in contro
cultured in complete medium in the absence or in the presence of PP2 inhibitor or PP3 inactiv
PP2, but not by PP3, treatment induced apoptosis in 40% EDSI and 49% EDSIV cells. The percThe activation of paxillin by tyrosine and serine phosphorylation
was analyzed in control and EDS cells by reacting the paxillin
immunoprecipitates with a speciﬁc anti-paxillin mAb and with anti-
P-Tyr and anti-P-Ser Abs (Fig. 6A). In EDS cells, tyrosine phosphory-
lated paxillin was present at a level 2.8 and 2.4-fold higher than in
control ﬁbroblasts (Fig. 6A). Fig. 6A also reports that in EDS cells,
contrary to control ﬁbroblasts, paxillin was not phosphorylated on
serine residues. Taken together, these data indicate that in EDS cells
paxillin is involved in the signal transduction elicited by the αvβ3
integrin through an uncommon tyrosine, and not serine, phosphor-
ylation pattern, differing from that observed in control ﬁbroblasts.
In order to identify in EDS cells the kinases phosphorylating paxillin
on tyrosine, but not on serine residues, the possible interaction of
paxillin with ILK and pp60src proteins was investigated. For this
purpose, paxillin immunoprecipitates from control and EDS cells were
analyzed byWestern blotting with anti-ILK mAb and anti-pp60src Ab.
ILK, detected in control cells as a 59 kDa band, was absent in EDS cells
(Fig. 6A), whereas pp60src protein, detectable as a 60 kDa band, was
increased by 1.9- to 3.1-fold in EDS cells, compared to control
ﬁbroblasts (Fig. 6A). These data indicate that in EDS cells paxillin
should bind to pp60src but not to ILK.
In addition, the Western blotting analysis of p130Cas, performed
with a speciﬁc mAb on paxillin immunoprecipitates, showed that in
EDS cells the levels of p130Cas co-puriﬁed with paxillin were lower
(4.5–5.0-fold) than in control ﬁbroblasts (Fig. 6A). This reduced
binding of paxillin to p130Cas may suggest a role of paxillin in the
disassembly of the actin cytoskeleton observed in EDS ﬁbroblasts.ted paxillin, for EDS cells survival. A: Paxillin immunoprecipitates, obtained from 48 h
ti-P-Ser, anti-ILK, anti-pp60src anti-p130Cas Abs. In EDS cells, tyrosine, but not serine,
130Cas levels than control ﬁbroblasts, and did not bind to ILK protein. B: Paxillin
th PP2 inhibitor or its PP3 inactive analogue, were immunoblotted with anti-paxillin and
levels comparable to those obtained in the absence of the PP2 inhibitor and its inactive
l cells, whereas abolished it in EDS ﬁbroblasts. C: Control, EDSI and EDSIV ﬁbroblasts,
e analogue, were analyzed by TUNEL assay. The inhibition of pp60src kinase activity by
ent values are means±SD of three independent experiments performed in triplicate.
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was analyzed through the pp60src kinase activity inhibition with the
PP2 inhibitor. Control and EDS cells grown for 48 h, were treated for
1 h with the PP2 inhibitor or with its inactive analogue PP3, and the
paxillin immunoprecipitates were reacted with the anti-P-Tyr mAb.
The treatment with PP2 did not affect paxillin levels in control and
EDS cells (Fig. 6B), but downloaded the tyrosine phosphorylation of
paxillin in control cells and almost abolished it in EDS cells (Fig. 6A,B).
On the contrary, PP3 had not effect on paxillin tyrosine phosphoryla-
tion (Fig. 6A,B), since the levels of phosphorylation in EDS cells were
2.3-fold higher than in control ﬁbroblasts. These data indicate that the
pp60src kinase activity is involved in paxillin tyrosine phosphoryla-
tion in EDS cells, whereas in control ﬁbroblasts the residual paxillin
phosphorylation, detected after PP2 treatment, should be due to other
kinase activities, such as FAK, known to be involved in this process.
Concerning the role of pp60src-mediated tyrosine phosphory-
lation of paxillin on EDS cells survival, control and EDS cells grown
for 48 h were treated for 20 h with PP2 or PP3 and the apoptotic
nuclei were evaluated. As reported in Fig. 6C, PP2, but not PP3
treatment, induced apoptosis in 40% and 49% EDSI and EDSIV cells,
respectively, whereas only 4% control ﬁbroblasts nuclei were frag-
mented. These data show that the tyrosine kinase activity exerted
by pp60src on paxillin is required for the maintenance of EDS cells
survival.
4. Discussion
In thisworkwe studied the role and themechanismof action exerted
in the maintenance of cell adhesion, proliferation and survival by the
αvβ3 integrin, peculiarly organizedby twoEDSdermalﬁbroblast strains,
carrying mutations in COL5A1 and COL3A1 genes. As previously
reported, the αvβ3 integrin organization was a common downstream
event induced by COL5A1 or COL3A1 genes mutations responsible for
the defective synthesis and organization of COLLV and COLLIII,
respectively [22]. The lack of these organized COLLs in the ECM down-
regulated the main COLL receptor, the α2β1 integrin, and induced the
α5β1 integrin disorganization, the disassembly of the FN-ECM, and the
recruitment on the whole cell surface of the αvβ3 FNR [22].
Here we report that in these EDS ﬁbroblast strains the αvβ3
integrin is the main FNR. Indeed, different experimental approaches
showed that these cells did not organize the αvβ5 and αvβ6 integrins
and poorly organized the αvβ1 integrin. It is known that the αvβ3
integrin efﬁciently binds to FN, supports the assembly of soluble FN
into the ECM, and induces its ﬁbrillogenesis, as well as the α5β1
integrin. The ECMs organized by these two integrins are similar for
insolubility, and are equally stabilized by disulﬁde bonds [53]. Since in
EDS cells the αvβ3 integrin was capable of organizing exogenous pFN
in a ﬁbrillar FN-ECM comparable with that detected in control cells
[22, this work], the FN-ECM disassembly observed in EDS ﬁbroblasts,
grown in the absence of pFN, did not depend on the αvβ3 integrin
organization, or on its inability to bind FN. This event could rather be
due to the low levels of FN present in EDS cells media [22].
The αvβ3 integrins allowed EDS cells in vitro adhesion, since they
were present either in focal and ﬁbrillar contacts at 60 min after cells
seeding [22]. Furthermore, the Ab-mediated inhibition of αvβ3, but
not of α5β1, αvβ5 or other β1-containing integrins, strongly reduced
EDS cells adhesion. On the contrary, the function inhibition of αvβ3
integrins did not affect control ﬁbroblasts adhesion. Therefore, in EDS
ﬁbroblasts, the αvβ3 integrin is the main adhesive integrin receptor.
In EDS cells, the αvβ3 integrin, organized at higher levels than in
control ﬁbroblasts, was involved in signal transduction, as demon-
strated by its activation by tyrosine phosphorylation, maintained for
several days after cells seeding. FN, though poorly organized in EDS
cells adhesion zones, and secreted in the culture media at lower levels
than in control ﬁbroblasts [22], should elicit the activation of αvβ3
integrin, organized in focal and ﬁbrillar adhesions, respectively, as theAb-mediated functional inhibition of this receptor, but not of α5β1,
αvβ5, or β1-containing FN integrins, almost completely abolished EDS
cells adhesion to FN, without affecting the adhesion to VN. The
immunoprecipitation with an anti- β3 Ab showed that the level of β3
phosphorylated subunits was higher in EDS than in control cells. The
αvβ3 integrin is known to be phosphorylated on the β3 subunit when
binding to the RGD peptide [54]. In K562 cells stably expressing the
αvβ3 integrin, Butler et al. [55] demonstrated that the β3 subunit was
phosphorylated when the cells adhered to VN, whereas its phosphor-
ylation was not required for the adhesion to FN. These data led us to
speculate that also in EDS cells the αvβ3 integrin organized in focal
adhesions should be involved in the adhesion to the substrate,
whereas the dimers organized in ﬁbrillar adhesions should not.
Although the evaluation of αvβ3 integrin phosphorylation distributed
in focal and ﬁbrillar adhesions was not ascertained, we can speculate
that also in this cell system the integrins involved in the cell adhesion
to FN should not be phosphorylated, whereas those organized in the
ﬁbrillar adhesions should be. In this view, in EDS cells the αvβ3
integrins, localized in distinct cell compartments, should be involved
in different functions and transduce different signals.
It is known that ﬁbroblasts lacking ECM anchorage undergo
growth arrest [18,1,4,2] and that the FN-ECM regulates the adhesion-
dependent survival [19]. EDS ﬁbroblasts, lacking the organized ECMs
of FN and COLLs, showed a proliferative potential comparable to that
of control ﬁbroblasts [22] and did not activate anoikis. The inhibi-
tion of FN by a blocking mAb, induced the anoikis in about 50% of EDS
cells, thus indicating that the low levels of FN secreted by these cells
[22], either organized or soluble, are required to maintain EDS cells
adhesion and to promote cell survival, likely mediated by αvβ3
phosphorylated integrin.
The inhibition of αvβ3 integrins also leads to anoikis in about 50%
of the EDS cells, therefore, these integrins are survival receptors for
EDS ﬁbroblasts. This function, already reported for αvβ3 integrin in
endothelial [16], and in tumor cells [17], suggests that the αvβ3
integrin organization might be a downstream event to rescue from
apoptosis the ECM-defective ﬁbroblasts.
The study of the signal transduction pathway switched on by αvβ3
integrin, and promoting EDS cells survival and proliferation, showed
that in adherent and growing EDS cells the active αvβ3 integrins did
not recruit FAK. This event could play a central role in the up-regulation
of caspases activity and in the down-regulation of the anti-apoptotic
Bcl-2 protein observed in EDS ﬁbroblasts. Indeed, it is known that
FAK modulates the PKB/AKT action, which, in turn, activates cyclin-
dependent cell cycle and inhibits pro-apoptotic stimuli, as well as Bad
protein and caspases involved in anoikis [27,33]. In EDS cells, the FAK
download could affect the PKB/AKT activity and the Bad/Bcl-2 ratio,
also caused by the reduction of Bcl-2 synthesis, thus leading to the
cytoskeleton disarray. In turn, the caspases activity could be invol-
ved in the disassembly of cytoskeleton, since tensin and actin, are
substrates for caspases proteolysis [38,39]. In EDS cells, Bcl-2 re-
duction, caspases activation, and cytoskeleton disarray coexist with
the αvβ3 integrin-mediated cell adhesion, proliferation, and survival.
These cells, therefore, show traits present in apoptotic cells, together
with control cells behaviours.
EDS cells, though in the absence of organized actin and tensin,
abundantly recruited talin, vinculin and paxillin. Vinculin and paxil-
lin showed a peculiar distribution since theywere present on thewhole
cell surface, as well as the αvβ3 integrin. These proteins are usually
organized in focal adhesions and are absent in FN-bound ﬁbrillar
adhesions, which contain α5β1 integrin, tensin, and talin [8,56]. In EDS
cells, therefore, the FN-ECM disassembly promotes the αvβ3 integrin-
mediated organization of a novel type of ﬁbrillar adhesions containing
talin, vinculin, and paxillin, but not tensin and α5β1 integrin.
In EDS cells, the αvβ3 integrin co-immunoprecipitated with
tyrosine, but not serine, phosphorylated paxillin. Paxillin tyrosine
phosphorylation is induced by multiple stimuli, including cell
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phosphorylate paxillin, and promote a FAK-mediated activation [57].
Paxillin is heavily phosphorylated on serinewhen ﬁbroblasts adhere to
FN [58]. In EDS cells adhered to the substrate, the αvβ3 integrins did
not interact with FAK and did bind to active paxillin. This structural
complex likely supports the survival of these cells, activating down-
stream signalling. ILK protein binding, co-localizing, and serine
phosphorylating paxillin in control ﬁbroblasts [59], did not co-
immunoprecipitate with paxillin in EDS cells. Therefore, the absence
of paxillin serine phosphorylation observed in these cells, might be an
effect of the down-regulation of ILK protein binding to paxillin.
Since the lack of ILK prevents the phosphorylation of PKB/AKT, and
the consequent expression of Bcl-2 protein [27,60], the loss of ILK,
together with the downloading of FAK, could lead in EDS cells to the
lack of Bcl-2 expression and caspases activation. On the other hand,
the loss of ILK could interfere with cytoskeleton organization [60].
In EDS cells, paxillin was bound to and tyrosine phosphorylated by
pp60src. The pp60src kinase action on paxillinwas crucial for EDS cells
survival, since paxillin phosphorylation downloading by pp60src
kinase activity inhibition, led to EDS cells apoptosis. These data show
that in EDS ﬁbroblasts the pp60src-activated paxillin signals for cells
survival instead of FAK.
In EDS cells, paxillin co-immunoprecipitated with reduced
amounts of p130Cas. This reduction might be due, at least partly, to
the active caspases present in these cells, which are known to degrade
p130Cas [36]. Otherwise, we cannot exclude that the absence of FAK
and its phosphorylating action, commonly exerted on paxillin and on
p130Cas, might result in the decrease of p130Cas recruitment. Since
p130Cas is involved in the remodelling of cytoskeleton during cell
adhesion andmotility [40], its low levels in EDS cells can be associated
to the decreased actin cytoskeleton present in these cells. Though
reduced, the p130Cas could activate the small GTPases Rac and Ras, as
well as JNK and ERK1/2–MAPK [41].
In EDS cells, the αvβ3 integrin also co-immunoprecipitated with
the phosphorylated EGFR, and EGFR function block induced the αvβ3
integrin disorganization. This partnership is involved in the rescue
from anoikis of EDS ﬁbroblasts, since the Ab-mediated inhibition of
either αvβ3 integrin or EGFR, induced apoptosis to comparable levels,
whereas the simultaneous inhibition of both receptors enhanced
apoptosis. The partnership between different integrins and growth
factors receptors has been reported [61–63]. In particular, integrins-
mediated cell adhesion to the ECM leads to ligand-independent
phosphorylation of several growth factor receptors, including EGFR
[64], which can elicit cell growth and survival in the absence of EGF. In
EDS cells, EGFwas present in the environment, as a serum component,
and, therefore, in basal culture conditions, EGFR was present in an
active form. These data show that a co-operation between EGFR and
αvβ3 integrins should occur in EDS cells.
The survival pathway identiﬁed in EDS cells likely replaces the
integrin-FAK-mediated signal transduction, activated when a rich,
ﬁbrillar and adhesive FN-ECM is present, independently or not from
EGF action and leading to MAPK activation [62,63]. A role of EGF and
EGFR in paxillin tyrosine phosphorylation [65], and of paxillin, as a
common adaptor protein capable to integrate and transduce signals
from growth factor receptors and integrins, eliciting cell proliferation
through the MAPK cascade, have been reported [66].
In conclusion, in this work we characterized a cell adhesion and
survival pathway in the pathological EDS skin ﬁbroblasts, which is
activated in the absence of an organized ﬁbrillar FN-ECM, and is
supported by the αvβ3–EGFR complexes. The active αvβ3–EGFR
complexes bound to FN and EGF, transduce to paxillin, instead than
to FAK and, through talin and vinculin binding, support cell adhesion in
the presence of a strongly reduced tensin and actin cytoskeleton.
Paxillin, activated by pp60src, likely activates the MAPK cascade by
a cross-talk with EGFR signalling, also co-operating with p130Cas.
p130Cas might also play a role in the maintenance of αvβ3 integrin–EGFR cooperation [41]. The αvβ3 integrins–paxillin complexes likely fail
to control the PKB/AKT–Bcl-2 pathway, thus favouring the activation of
the apoptotic pathway. Though the MAPK cascade and AKT were not
investigated in this work, our data describe a peculiar adhesive
structure which supports cell proliferation, and prevents anoikis
activation in cells with damaged ECM and cytoskeleton structures.
These results add new insights in the complexity of integrin-mediated
cell adhesion and on the interaction of αvβ3 integrin with alternative
settings of the adhesome [12] leading to cell survival.
Although the αvβ3-mediated cell survival pathway was demon-
strated only in two dermal ﬁbroblasts derived from patients affec-
ted with EDSI and EDSIV, the disassembly of the FN-ECM and the
organization of the αvβ3 integrin were reported in skin ﬁbroblasts
from all EDS types [22,50–52]. These strains, when grown in the
absence of serum undergo apoptosis, therefore, the survival mechan-
ism here reported and activated by αvβ3 integrin might be a common
feature of all ﬁbroblasts from different EDS types. In a recent work we
reported that three different EDSI ﬁbroblast strains show a defective
migration and retarded repair in a monolayers wounding assay, which
are rescued by treatment with puriﬁed COLLV [52]. The knowledge of
the molecular mechanism regulating cell survival in FN-ECM deﬁ-
cient and αvβ3+ in vitro cultured cells should give insights in the
comprehension of dermal ﬁbroblasts properties in vivo and address
therapeutic approaches for an effective wound healing in EDS patients.
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